Business Description
Cogstate is an Australian company founded in 1999 that develops and sells digital tools for measuring brain health and cognitive performance. Their assessments are used in clinical trials across a wide range of conditions, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and schizophrenia, helping researchers understand how diseases and treatments affect the human mind. The company works with pharmaceutical and biotech firms, academic institutions, and healthcare providers around the world, offering services that range from data quality management to scientific consulting and cognitive screening for primary care settings.
